PERCEPTIVE ADVISORS LLC 13D and 13G filings for Aldeyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 9,275,851 15.600% | 682,265 (+7.94%) | Filing |
| 2024-02-14 4:52 pm Unchanged | 2023-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 8,593,586 14.600% | 0 (Unchanged) | Filing |
| 2023-10-18 6:07 pm Sale | 2023-10-16 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 8,593,586 14.700% | -2,756,499 (-24.29%) | Filing |
| 2023-02-14 2:33 pm Purchase | 2022-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 11,350,085 19.400% | 1,446,206 (+14.60%) | Filing |
| 2022-02-14 3:45 pm Purchase | 2021-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 9,903,879 17.000% | 1,200,000 (+13.79%) | Filing |
| 2021-02-16 3:31 pm Purchase | 2020-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 8,703,879 19.100% | 2,418,421 (+38.48%) | Filing |
| 2020-07-13 4:30 pm Purchase | 2020-07-09 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 6,285,458 19.100% | 3,200,000 (+103.71%) | Filing |